T1D=type 1 diabetes.
References: 1. Prescribing Information. Provention Bio, Inc; 2023. 2. diaTribe Learn. FDA approves Tzield (teplizumab) to delay type 1 diabetes. Published November 17, 2022. Updated November 21, 2022. https://diatribe.org/fda-approves-tzield-teplizumab-delay-type-1-diabetes 3. Thakkar S, Chopra A, Nagendra L, et al. Teplizumab in type 1 diabetes mellitus: an updated review. touchREV Endocrinol. 2023;19(2):22-30. 4. Pham-Huy A, Top KA, Constantinescu C, et al. The use and impact of monoclonal antibody biologics during pregnancy. CMAJ. 2021;193(29):1129-1136. 5. American Diabetes Association Diabetes Dialogues. Insulin is now a biologic—what does that mean? Accessed April 15, 2024. https://diabetes.org/blog/insulin-now-biologic-what-does-mean 6. Sims EK, Carr ALJ, Oram RA, et al. 100 years of insulin: celebrating the past, present and future of diabetes therapy. Nat Med. 2021;27(7):1154-1164. 7. Simmons KMW, Frohnert BI, O’Donnell HK, et al. Historical insights and current perspectives on the diagnosis and management of presymptomatic type 1 diabetes. Diabetes Technol Ther. 2023;25(11):790-799.